Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines

Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines

Bibliographic Details
Main Authors:	Srujan Marepally, Tejram Sahu, Rajeev K. Tyagi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Pharmacology
Subjects:	nanoscale drug carriers inflammation pseudovirus tuberculosis gene editing anti-bacterial therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.928572/full

Similar Items

A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies
by: Yao Su, et al.
Published: (2018-12-01)

Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development
by: Sheng-Wen Huang, et al.
Published: (2020-08-01)

Polymalic acid for translational nanomedicine
by: Xing Huang, et al.
Published: (2022-06-01)

VITALITY AND MORPHOLOGY OF TUMOR CELLS TREATED WITH 4-TIAZOLIDINONE DERIVATIVES IMMOBILIZED ON NANOSCALE POLYMER CARRIER
by: N. M. Boiko, et al.
Published: (2015-02-01)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
by: Yongfang Lin, et al.
Published: (2024-06-01)

Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses
by: Syamala R. Thimmiraju, et al.
Published: (2024-12-01)

Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells
by: Ramya Murugesan, et al.
Published: (2023-09-01)

Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies
by: Anna Godi, et al.
Published: (2022-06-01)

Recent Advances in Nanotechnology-Based Strategies for Bone Tuberculosis Management
by: Yuanrui Luo, et al.
Published: (2024-01-01)

Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants
by: Hsin-I Wang, et al.
Published: (2021-08-01)

Vaginal pH value can affect the susceptibility to human papillomavirus infection
by: Yinxia Liu, et al.
Published: (2024-02-01)

Detection of antibodies against H5 and H7 strains in birds: evaluation of influenza pseudovirus particle neutralization tests
by: Sofie Wallerström, et al.
Published: (2014-01-01)

Edible plant extracellular vesicles: An emerging tool for bioactives delivery
by: Shi-Jie Fan, et al.
Published: (2022-12-01)

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
by: Jeroen Pollet, et al.
Published: (2021-08-01)

Research Progress in Exosome-Based Nanoscale Drug Carriers in Tumor Therapies
by: Wei Fu, et al.
Published: (2022-06-01)

Predicting Associations of miRNAs and Candidate Gastric Cancer Genes for Nanomedicine
by: Aigul Akimniyazova, et al.
Published: (2021-03-01)

An optimized method for counting viral particles using electron microscopy
by: B. N. Zaitsev, et al.
Published: (2019-05-01)

High Thermoelectric Performance Achieved in Sb-Doped GeTe by Manipulating Carrier Concentration and Nanoscale Twin Grains
by: Chao Li, et al.
Published: (2022-01-01)

AFM Study of Nanoscale Membrane Perturbation Induced by Antimicrobial Lipopeptide C<sub>14</sub> KYR
by: Sawinee Nasompag, et al.
Published: (2021-06-01)

Synthesis, Characterization, Spectroscopic and Biological Studies of Zn(Ⅱ), Mn(Ⅱ) and Fe(Ⅱ) Theophylline Complexes in Nanoscale
by: Ahmad Hussein Ismail, et al.
Published: (2020-09-01)

Nanostructured Lipid Carriers for the Formulation of Topical Anti-Inflammatory Nanomedicines Based on Natural Substances
by: Kézia Cristine Barbosa Ferreira, et al.
Published: (2021-09-01)

Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends
by: Chun-Yan Shih, et al.
Published: (2021-02-01)

Carrier-free curcumin nanoassemblies for enhancing therapy effects in inflammation related disease
by: Liangjun Zhang, et al.
Published: (2022-10-01)

Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance
by: Mayur Kumar, et al.
Published: (2018-01-01)

Selected Aspects Of The Crispr-Cas Biology And Applications
by: Wawszczak Monika, et al.
Published: (2021-01-01)

Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2
by: Davide Gentile, et al.
Published: (2024-02-01)

HIV-1 pseudoviruses constructed in China regulatory laboratory
by: Jianhui Nie, et al.
Published: (2020-01-01)

Generation of JC Polyoma Pseudovirus for High-Throughput Measurement of Neutralizing Antibodies
by: Mami Matsuda, et al.
Published: (2024-01-01)

COVID-19: S-Peptide RBD <sub>484–508</sub> Induces IFN-γ T-Cell Response in Naïve-to-Infection and Unvaccinated Subjects with Close Contact with SARS-CoV-2-Positive Patients
by: Michela Murdocca, et al.
Published: (2023-06-01)

A simple and safe antibody neutralization assay based on polio pseudoviruses
by: Zheng Jiang, et al.
Published: (2019-02-01)

Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactant
by: Govind Gupta, et al.
Published: (2022-12-01)

Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1
by: N. B. Rudometova, et al.
Published: (2022-04-01)

Advances of Cobalt Nanomaterials as Anti-Infection Agents, Drug Carriers, and Immunomodulators for Potential Infectious Disease Treatment
by: Yuhe Ma, et al.
Published: (2022-10-01)

A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses
by: Sarah Brendle, et al.
Published: (2021-12-01)

Editorial: Advances on targeted nanomedicines for atherosclerosis
by: Qinggong Han, et al.
Published: (2022-10-01)

Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step
by: Shiu-Wan Chan, et al.
Published: (2021-11-01)

Neutropenic patients and their infectious complications at a University Hospital
by: Stella Sala Soares Lima, et al.
Published: (2013-01-01)

Determination of Binding Affinity of Antibodies to HIV-1 Recombinant Envelope Glycoproteins, Pseudoviruses, Infectious Molecular Clones, and Cell-Expressed Trimeric gp160 Using Microscale Thermophoresis
by: Shraddha Basu, et al.
Published: (2023-12-01)

Macrophage-Targeted Berberine-Loaded β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis
by: Xu Y, et al.
Published: (2022-11-01)

Non-Functionalized Gold Nanoparticles Inhibit Human Papillomavirus (HPV) Infection
by: Diana Gabriela Valencia-Reséndiz, et al.
Published: (2022-07-01)